D. Anticoagulant & Antiviral Candidates

Two Anticoagulant & Antiviral Drug Candidates

May 19, 2020
Tirofiban-C22H36N2O5S[1]
Heparin- C26H42N2O37S5[2-5]

Note that the combination of Tirofiban with Heparin is a common practice for treatment of acute coronary syndrome. Major functions of Tirofiban are described in the following.



[1] ClinicalTrials.gov Identifier: NCT04368377. April 29, 2020.

[2] ClinicalTrials.gov Identifier: NCT04345848. April 15, 2020.

[3] ClinicalTrials.gov Identifier: NCT04362085. April24, 2020.

[4] ClinicalTrials.gov Identifier: NCT04367831. April29, 2020.

[5] ClinicalTrials.gov Identifier: NCT04373707. May 4, 2020.